Quiz 4: DA, 5-HT, Glu, GABA, Pain Flashcards
DA neurons are found in the
(2)
- SN
- (substanstia nigra)
- VTA
- (ventral tegmental area)
Which of the following is believed to be increased in the nucleus accumbens by all drugs of abuse.
DA
Most antipsychotic drugs are
D2-like receptor antagonists
AADC
(5)
- Is also called dopa decarboxylase
- is required for the synthesis of DA, NE, and 5-HT (5-HT is serotonin).
- is inhibited by carbidopa
- converts L-DOPA to DA
- converts 5-HTP to 5-HT
Does NOT converts DA to NE
Parkinson’s disease is caused by the degeneration of
(3)
- DA neurons in the substantia nigra
- DA terminals in the basal ganglia
- nigrostriatal DA neurons
Not found in:
- DA terminals in the motor cortex
- mesolimbic DA neurons
- mesocortical DA neuron
- Striatal neurons
Which of the following is found in both serotonin and catecholamine neurons?
(4)
- AADC
- Dopa decarboxylase
- MAO
- VMAT
- The vesicular monoamine transporter acts to transport monoamine neurotransmitters – such as dopamine, serotonin, norepinephrine, epinephrine, and histamine – into the vesicles, which release the neurotransmitters into synapses as chemical messages to postsynaptic neurons.
In which of the following diseases is there reason to believe that the mesolimbic DA system is hypoactive?
Major depression
Notes: mesolimbic dopamine system is composed of the VTA (ventral tegumental area) and NAc (nucleus accumbens) and controls an individual’s responses to natural rewards, such as food, sex, and social interactions, and is therefore an important determinant of motivation and incentive drive.
Which of the following are used for the treatment of the motor symptoms of Parkinson’s disease?
(3)
-
D2 agonists
- Notes: act directly on dopamine receptors and mimicking the endogenous neurotransmitter.
-
MAO_B_ inhibitors
- Notes: help to block the break down of dopamine in the brain, thus making more dopamine available and reducing some of the motor symptoms associated with PD
-
mAchR antagonists
- Notes: muscarinic acetylcholine receptors
Are not aused for treatment of PD: MAOA inhibitors or D1 agonists
AADC is present in
almost all cell types in the body
Which of the following statements are true?
- D1-like receptors are Gi-coupled receptors
- D2-like receptors are Gi-coupled receptors
- DA autoreceptors are D2-like receptors.
- DA autoreceptors are D1-like receptors.
- Activation of DA autoreceptors inhibits DA neurons
- D1-like receptors are Gi-coupled receptors
- D2-like receptors are Gi-coupled receptors
- DA autoreceptors are D2-like receptors.
- DA autoreceptors are D1-like receptors.
- Activation of DA autoreceptors inhibits DA neurons
In which of the following diseases is there reason to believe that the mesocortical DA system is hypoactive?
Schizophrenia
Aripiprazole is an
(2)
- antipsychotic drug
- DA agonist
- Notes: is a D2-like receptor and partial D2 agonist
Which of the following are used for the treatment of the motor symptoms of Parkinson’s disease?
(2)
-
COMT inhibitors
- Tolcapone (xBBB), Entacapone
-
AADC inhibitors
- Given with L-Dopa
- Do not cross BBB
ARE NOT used for treatment of motor symptoms of PD:
- DAT inhibitors
- SSRIs
- Antipsychotic drugs
Extrapyramidal Syndromes (EPS)
(2)
- may be reduced by antiparkinsonian drugs
- L-Dopa
- DA agonists
- MAOB inhibitors
- Non-DA drugs
- are side effects of antipsychotic drugs
- typical antipsychotic drugs - 1st generation
- are D2 antagonists (Chlorpromazine, haloperidol, fluphenazine)
- also cause prolactin secretion
Most antipsychotic drugs are
(2)
- Effective in improving positive symptoms
- Capable of increasing DA release
Amphetamine-like psychostimulants increase the extracellular levels of
(3)
- NE
- 5-HT
- DA
Note: Cocaine and MDMA (Ecstasy) also increase these levels of reuptake inhibitors
The 5-HT-mediated synaptic transmission can be enhanced by the following except:
- Inhibition of COMT
- Inhibition of MAOA
- Inhibition of MAOB
- Blockade of VMAT
- Blockade of 5-HTT
- Blockade of 5-HT1A/1D autoreceptors
- Blockade of α1 receptors on 5-HT neurons
- Activation of tryptophan hydroxylase
The 5-HT-mediated synaptic transmission cannot be enhanced by:
- Inhibition of COMT
- Inhibition of MAOB
- Blockade of VMAT
- Blockade of α1 receptors on 5-HT neurons
The 5-HT-mediated synaptic transmission can be enhanced by:
- Inhibition of MAOA
- Blockade of 5-HTT
- Blockade of 5-HT1A/1D autoreceptors
- Activation of tryptophan hydroxylase
Triptans are
- 5-HT1B/D agonists
- drugs for treatment of migraine